93 related articles for article (PubMed ID: 7792735)
1. Internalization and degradation of recombinant human coagulation factor VIIa by the human hepatoma cell line HuH7.
Chang GT; Kisiel W
Thromb Haemost; 1995 Feb; 73(2):231-8. PubMed ID: 7792735
[TBL] [Abstract][Full Text] [Related]
2. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling.
Sathre KA; Tsang ML; Weatherbee JA; Steer CJ
Hepatology; 1991 Aug; 14(2):287-95. PubMed ID: 1650327
[TBL] [Abstract][Full Text] [Related]
3. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa.
Reuning U; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434
[TBL] [Abstract][Full Text] [Related]
4. IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts.
Chizzonite R; Truitt T; Desai BB; Nunes P; Podlaski FJ; Stern AS; Gately MK
J Immunol; 1992 May; 148(10):3117-24. PubMed ID: 1578138
[TBL] [Abstract][Full Text] [Related]
5. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation.
Sakai T; Lund-Hansen T; Paborsky L; Pedersen AH; Kisiel W
J Biol Chem; 1989 Jun; 264(17):9980-8. PubMed ID: 2785997
[TBL] [Abstract][Full Text] [Related]
6. Distribution of the recombinant coagulation factor 125I-rFVIIa in rats.
Beeby TL; Chasseaud LF; Taylor T; Thomsen MK
Thromb Haemost; 1993 Sep; 70(3):465-8. PubMed ID: 8259550
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of recombinant factor VIIa in the rat--a comparison of bio-, immuno- and isotope assays.
Thomsen MK; Diness V; Nilsson P; Rasmussen SN; Taylor T; Hedner U
Thromb Haemost; 1993 Sep; 70(3):458-64. PubMed ID: 8259549
[TBL] [Abstract][Full Text] [Related]
8. Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cells.
Wun TC; Kretzmer KK; Palmier MO; Day KC; Huang MD; Welsch DJ; Lewis C; Wolfe RA; Zobel JF; Lange GW
Thromb Haemost; 1992 Jul; 68(1):54-9. PubMed ID: 1325078
[TBL] [Abstract][Full Text] [Related]
9. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of recombinant human blood coagulation factor VIIa amidolytic and proteolytic activity by zinc ions.
Pedersen AH; Lund-Hansen T; Komiyama Y; Petersen LC; Oestergård PB; Kisiel W
Thromb Haemost; 1991 May; 65(5):528-34. PubMed ID: 1871714
[TBL] [Abstract][Full Text] [Related]
11. Bioactive human recombinant tumor necrosis factor-alpha: an unstable dimer?
Petersen CM; Nykjaer A; Christiansen BS; Heickendorff L; Mogensen SC; Møller B
Eur J Immunol; 1989 Oct; 19(10):1887-94. PubMed ID: 2583226
[TBL] [Abstract][Full Text] [Related]
12. Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.
Li YM; Arkins S; McCusker RH; Donovan SM; Liu Q; Jayaraman S; Dantzer R; Kelley KW
J Immunol; 1996 Jan; 156(1):64-72. PubMed ID: 8598495
[TBL] [Abstract][Full Text] [Related]
13. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
Iino M; Foster DC; Kisiel W
Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
[TBL] [Abstract][Full Text] [Related]
14. Binding and degradation of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
Otter M; Van Berkel TJ; Rijken DC
Thromb Haemost; 1989 Sep; 62(2):667-72. PubMed ID: 2510347
[TBL] [Abstract][Full Text] [Related]
15. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
16. Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma.
Molinas FC; Wietzerbin J; Falcoff E
J Immunol; 1987 Feb; 138(3):802-6. PubMed ID: 2949008
[TBL] [Abstract][Full Text] [Related]
17. Effect of glycoPEGylation on factor VIIa binding and internalization.
Sen P; Ghosh S; Ezban M; Pendurthi UR; Vijaya Mohan Rao L
Haemophilia; 2010 Mar; 16(2):339-48. PubMed ID: 19845776
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method.
Halabian R; Roudkenar MH; Esmaeili NS; Masroori N; Roushandeh AM; Najafabadi AJ
Vox Sang; 2009 May; 96(4):309-15. PubMed ID: 19175565
[TBL] [Abstract][Full Text] [Related]
19. Cellular pathways of galactose-terminal ligand movement in a cloned human hepatoma cell line.
Simmons CF; Schwartz AL
Mol Pharmacol; 1984 Nov; 26(3):509-19. PubMed ID: 6092900
[TBL] [Abstract][Full Text] [Related]
20. Identification and pharmacological characterization of somatostatin receptors in rat lung.
Schloos J; Raulf F; Hoyer D; Bruns C
Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
